TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 24,589 | 16,649 | 16,119 |
Financial expenses | 4 | 1 | 23 |
Earnings before taxes | 167 | -9,261 | -9,053 |
EBITDA | 2,196 | -8,949 | -7,306 |
Total assets | 26,890 | 30,041 | 28,053 |
Current assets | 22,108 | 25,584 | 17,953 |
Current liabilities | 6,530 | 4,433 | 6,298 |
Equity capital | 20,299 | 25,542 | 18,773 |
- share capital | 16,856 | 18,341 | 18,695 |
Employees (average) | 20 | 16 | 18 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 75.5% | 85.0% | 66.9% |
Turnover per employee | 1,229 | 1,041 | 896 |
Profit as a percentage of turnover | 0.7% | -55.6% | -56.2% |
Return on assets (ROA) | 0.6% | -30.8% | -32.2% |
Current ratio | 338.6% | 577.1% | 285.1% |
Return on equity (ROE) | 0.8% | -36.3% | -48.2% |
Change turnover | 9,288 | 835 | -4,892 |
Change turnover % | 61% | -23% | |
Chg. No. of employees | 4 | -2 | 0 |
Chg. No. of employees % | 25% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.